Market Overview

Jim Cramer Weighs In On CVS, Starbucks, Tilray And More


On CNBC's "Mad Money Lightning Round," Jim Cramer said Starbucks Corporation (NASDAQ: SBUX) is doing well. The stock traded higher on Tuesday, which is a sign of great strength.

Penumbra Inc (NYSE: PEN) is a medical device company, but Cramer is not that familiar with it. He added that he likes DexCom, Inc. (NASDAQ: DXCM).

Healthequity Inc (NASDAQ: HQY) is a very interesting company and it can be much bigger than it really is, said Cramer. He really likes it.

Cramer can't recommend Turning Point Brands Inc (NYSE: TPB) because it's a tobacco stock.

Instead of Tilray Inc (NASDAQ: TLRY), Cramer would buy Canopy Growth Corp (NYSE: CGC). He explained that Tilray's ownership structure is messed up.

CVS Health Corp (NYSE: CVS) is a bargain at its current price level, believes Cramer. He thinks the last quarter was good.

Timken Co (NYSE: TKR) represents the best of American manufacturing, said Cramer.


Related Articles (SBUX + PEN)

View Comments and Join the Discussion!

Posted-In: CNBC Jim Cramer Mad Money mad money Lightning RoundMedia